Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
17.23
-0.32 (-1.82%)
At close: Jun 26, 2026, 4:00 PM EDT
17.27
+0.04 (0.23%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $2.22 billion as of June 26, 2026. Its market cap has increased by 102.73% in one year.
Market Cap
2.22B
Enterprise Value
1.91B
1-Year Change
102.73%
Ranking
Category
Stock Price
$17.23
Market Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $2.22B, an increase of 1,665.58%. That is a compound annual growth rate of 27.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.22B | 5.37% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 2.30B |
| Immunome | 2.26B |
| Agios Pharmaceuticals | 2.25B |
| AbCellera Biologics | 2.25B |
| Kodiak Sciences | 2.24B |
| Mineralys Therapeutics | 2.20B |
| Ocular Therapeutix | 2.15B |
| Nektar Therapeutics | 2.15B |